CD8A and neoplasm: It has recently been shown that CB-1158 (arginase inhibitor) can rescue the suppressed proliferation of T cells mediated by myeloid cells in vitro [162], and can increase the number of tumor-infiltrating CD8+ T cells and NK cells, reducing tumor growth, in vivo [162].